A prominent food technology investor supporting alternative protein solutions.
Portfolio
3
companies
Bright Biotech
Bright Biotech manufactures growth factors in plants to produce affordable cultivated meat at scale.
ENOUGH
ENOUGH produces sustainable mycoprotein ingredients through zero-waste fermentation to supply the plant-based food market.
Hoxton Farms
Hoxton Farms produces cultivated animal fat to improve meat alternatives.
Harry Kalms
The financing round was co-led by World Fund and CPT Capital to help scale sustainable protein production in Europe.
"Our strides in launching the new factory in the Netherlands and expanding collaborations across the UK and Europe have been significant. This fresh funding will drive accelerated growth."
The oversubscribed round was led by FoodLabs to support research and manufacturing expansion.
"We are glad to have won such renowned and like-minded investors backing our vision for a more sustainable food system"
Collaborative Fund and Fine Structure Ventures led the round to support the scale up of cultivated fat manufacturing.
"At Hoxton Farms, we are obsessed with fat. Fat is the single most important sensory component in all of the meat that we eat. Using cultivated fat alongside plant proteins, we have shown that we can make products with the juiciness and flavour that plant-based meat has been missing. We’re now building our pilot plant in central London so that we can show visitors a new way of making the same delicious meat."